FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1825742435> ?p ?o ?g. }

• W1825742435 endingPage "718" @default.
• W1825742435 startingPage "713" @default.
• W1825742435 abstract "BACKGROUND/AIMS: Nonalcoholic steatohepatitis (NASH) is a serious disorder with the potential to gradually progress to cirrhosis. It is generally associated with obesity, diabetes and hyperlipidemia. Currently, there is no established therapy for NASH. The aim of the present study was to evaluate the effectiveness of atorvastatin and ursodeoxycholic acid (UDCA) in the treatment of NASH. METHODS: This prospective study included 44 adult patients (24 men, 20 women) with a mean age of 48.90±7.69 years and mean body mass index (BMI) of 29.40±3.82. Ten patients had a history of diabetes. Serological markers for viral hepatitis were negative in all patients and there was no history of alcohol or drug abuse. Patients who had autoimmune hepatitis were excluded from the study. Liver biopsy was performed before therapy to confirm the diagnosis. Among NASH patients, 17 normolipidemic cases received UDCA 13 to 15 mg/kg/day (group 1), while hyperlipidemic cases (n=27) received atorvastatin 10 mg/day (group 2) for six months. The BMI, serum lipids, liver function tests and liver density, assessed by computerized tomography, were evaluated before and after the treatment period. The BMI, serum aminotransferase levels, histological parameters (steatosis, inflammation, fibrosis scores) and liver densities were not statistically different between the groups at the beginning of therapy. RESULTS: The BMI, serum glucose, and triglyceride levels did not change in either group after the treatment period. In group 1, serum alanine aminotransferase (ALT) and gamma-glutamyl-transferase (GGT) levels reduced significantly, and in group 2, serum cholesterol, aspartate aminotransferase, ALT, alkaline phosphatase and GGT levels reduced significantly. Liver densities increased only in group 2, probably as a result of diminishing fat content of liver. The normalization of transaminases was also more prevalent in group 2. Liver steatosis was closely correlated with liver density, but inflammation and fibrosis were not. CONCLUSIONS: The use of atorvastatin in NASH patients with hyperlipidemia was found to be both effective and safe. The benefit of statin and UDCA therapy in normolipidemic patients with NASH requires confirmation with further placebo-controlled trials." @default.
• W1825742435 created "2016-06-24" @default.
• W1825742435 creator A5012052658 @default.
• W1825742435 creator A5014948916 @default.
• W1825742435 creator A5026574837 @default.
• W1825742435 creator A5031455492 @default.
• W1825742435 creator A5036498784 @default.
• W1825742435 creator A5036839598 @default.
• W1825742435 creator A5049189341 @default.
• W1825742435 creator A5073768568 @default.
• W1825742435 creator A5074532315 @default.
• W1825742435 date "2003-01-01" @default.
• W1825742435 modified "2023-10-14" @default.
• W1825742435 title "Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis" @default.
• W1825742435 cites W1986323764 @default.
• W1825742435 cites W2024533096 @default.
• W1825742435 cites W2076204761 @default.
• W1825742435 cites W2079756525 @default.
• W1825742435 cites W2087829753 @default.
• W1825742435 cites W2123856468 @default.
• W1825742435 cites W2165903833 @default.
• W1825742435 cites W2327546859 @default.
• W1825742435 cites W2615637571 @default.
• W1825742435 doi "https://doi.org/10.1155/2003/857869" @default.
• W1825742435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14679419" @default.
• W1825742435 hasPublicationYear "2003" @default.
• W1825742435 type Work @default.
• W1825742435 sameAs 1825742435 @default.
• W1825742435 citedByCount "182" @default.
• W1825742435 countsByYear W18257424352012 @default.
• W1825742435 countsByYear W18257424352013 @default.
• W1825742435 countsByYear W18257424352014 @default.
• W1825742435 countsByYear W18257424352015 @default.
• W1825742435 countsByYear W18257424352016 @default.
• W1825742435 countsByYear W18257424352017 @default.
• W1825742435 countsByYear W18257424352018 @default.
• W1825742435 countsByYear W18257424352019 @default.
• W1825742435 countsByYear W18257424352020 @default.
• W1825742435 countsByYear W18257424352021 @default.
• W1825742435 countsByYear W18257424352022 @default.
• W1825742435 countsByYear W18257424352023 @default.
• W1825742435 crossrefType "journal-article" @default.
• W1825742435 hasAuthorship W1825742435A5012052658 @default.
• W1825742435 hasAuthorship W1825742435A5014948916 @default.
• W1825742435 hasAuthorship W1825742435A5026574837 @default.
• W1825742435 hasAuthorship W1825742435A5031455492 @default.
• W1825742435 hasAuthorship W1825742435A5036498784 @default.
• W1825742435 hasAuthorship W1825742435A5036839598 @default.
• W1825742435 hasAuthorship W1825742435A5049189341 @default.
• W1825742435 hasAuthorship W1825742435A5073768568 @default.
• W1825742435 hasAuthorship W1825742435A5074532315 @default.
• W1825742435 hasBestOaLocation W18257424351 @default.
• W1825742435 hasConcept C126322002 @default.
• W1825742435 hasConcept C134018914 @default.
• W1825742435 hasConcept C2775934546 @default.
• W1825742435 hasConcept C2776175330 @default.
• W1825742435 hasConcept C2776954865 @default.
• W1825742435 hasConcept C2777214474 @default.
• W1825742435 hasConcept C2777482532 @default.
• W1825742435 hasConcept C2777766500 @default.
• W1825742435 hasConcept C2778772119 @default.
• W1825742435 hasConcept C2779091943 @default.
• W1825742435 hasConcept C2779134260 @default.
• W1825742435 hasConcept C2779478299 @default.
• W1825742435 hasConcept C2780221984 @default.
• W1825742435 hasConcept C2780965833 @default.
• W1825742435 hasConcept C2992208098 @default.
• W1825742435 hasConcept C512861765 @default.
• W1825742435 hasConcept C555293320 @default.
• W1825742435 hasConcept C71924100 @default.
• W1825742435 hasConcept C90924648 @default.
• W1825742435 hasConceptScore W1825742435C126322002 @default.
• W1825742435 hasConceptScore W1825742435C134018914 @default.
• W1825742435 hasConceptScore W1825742435C2775934546 @default.
• W1825742435 hasConceptScore W1825742435C2776175330 @default.
• W1825742435 hasConceptScore W1825742435C2776954865 @default.
• W1825742435 hasConceptScore W1825742435C2777214474 @default.
• W1825742435 hasConceptScore W1825742435C2777482532 @default.
• W1825742435 hasConceptScore W1825742435C2777766500 @default.
• W1825742435 hasConceptScore W1825742435C2778772119 @default.
• W1825742435 hasConceptScore W1825742435C2779091943 @default.
• W1825742435 hasConceptScore W1825742435C2779134260 @default.
• W1825742435 hasConceptScore W1825742435C2779478299 @default.
• W1825742435 hasConceptScore W1825742435C2780221984 @default.
• W1825742435 hasConceptScore W1825742435C2780965833 @default.
• W1825742435 hasConceptScore W1825742435C2992208098 @default.
• W1825742435 hasConceptScore W1825742435C512861765 @default.
• W1825742435 hasConceptScore W1825742435C555293320 @default.
• W1825742435 hasConceptScore W1825742435C71924100 @default.
• W1825742435 hasConceptScore W1825742435C90924648 @default.
• W1825742435 hasIssue "12" @default.
• W1825742435 hasLocation W18257424351 @default.
• W1825742435 hasLocation W18257424352 @default.
• W1825742435 hasLocation W18257424353 @default.
• W1825742435 hasOpenAccess W1825742435 @default.
• W1825742435 hasPrimaryLocation W18257424351 @default.
• W1825742435 hasRelatedWork W1998556725 @default.
• W1825742435 hasRelatedWork W2017997482 @default.

• next